HTG Appoints Biopharmaceutical Industry VeteranChristopher Kiritsy to its Board of Directors

Brings Significant Operational Experience in Building Therapeutic Drug Development Businesses TUCSON, Ariz. , Jan. 28, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide